These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 982333)

  • 1. The effect of the aminoketone nioben in essential circulatory hyperkinesis.
    Szám I; Büky P
    Ther Hung; 1976; 24(1):17-9. PubMed ID: 982333
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of Mydocalm in ophthalmology.
    Pál M
    Ther Hung; 1967; 15(3):123-6. PubMed ID: 6081647
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of Mydeton on the psychic activity in cases of mental retardation].
    Schwabik J; Péterfai J
    Orv Hetil; 1967 Jan; 108(4):157-60. PubMed ID: 6047454
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization of the myorelaxant action of mydocalm in the clinical practice.
    Perényi G
    Ther Hung; 1978; 26(3):107-10. PubMed ID: 725813
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of myocalm on the hemodynamics of peripheral and kidney circulation in subjects with healthy blood vessels and in patients with obliterative arterial vascular diseases].
    Hackel F
    Z Gesamte Inn Med; 1966 Jul; 21(14):435-9. PubMed ID: 5992292
    [No Abstract]   [Full Text] [Related]  

  • 6. [Personal experiences with myotonolytics].
    Vurdelja N; Orovcanec K
    Med Pregl; 1969; 22(5-6):263-6. PubMed ID: 5396216
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peripheral vascular diseases and generalized scleroderma treated with mydocalm].
    Lukasiak B; Szczepański A; Rózański J; Wnorowski J
    Przegl Dermatol; 1973; 60(3):383-9. PubMed ID: 4748081
    [No Abstract]   [Full Text] [Related]  

  • 8. Arterio-venous disorders influenced centrally with Mydocalm.
    Fric M; Kozák P; Martinek J; Wimmer P
    Ther Hung; 1974; 22(3):108-11. PubMed ID: 4445978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Assessment of the action of Sadamine Polfa and Mydocalm Richter preparations as based on photoplethysmography].
    Chwistecki K; Bochenek W; Lawiński M
    Pol Tyg Lek; 1975 Dec; 30(50):2093-6. PubMed ID: 1197101
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and neuropsychological effects of the novel antidepressant bupropion.
    Clay TH; Gualtieri CT; Evans RW; Gullion CM
    Psychopharmacol Bull; 1988; 24(1):143-8. PubMed ID: 3133717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status of the therapy of multiple sclerosis].
    Bas H
    Ther Ggw; 1967 Oct; 106(10):1319-25. PubMed ID: 4314784
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative blood flow of the calf in arterial occlusive diseases of the combined and femoral type during intravenous and intra-arterial administration of Mydocalm].
    Hackel F
    Z Gesamte Inn Med; 1968 Feb; 23(4):109-17. PubMed ID: 5686874
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of trihydroxy propiophenone on subjective symptoms (especially in bile duct diseases)].
    Miyoshi S
    Naika Hokan; 1967 Jun; 14(6):187-91. PubMed ID: 5624698
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant effect of oral Mydocalm treatment with massive doses in locomotor disease patients.
    Konrád K
    Ther Hung; 1987; 35(3):152-5. PubMed ID: 3438877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of sulfinpyrazone(Anturan) on the uric acid metabolism in malignant blood diseases].
    de Carvalho RI; Givisiez AN; Cardoso JR
    Hospital (Rio J); 1969 Apr; 75(4):1343-55. PubMed ID: 5306426
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic attempts with human growth hormone in hematologic diseases].
    Stobbe H; Neumann P; Knappe G; Bach G
    Z Gesamte Inn Med; 1968 Aug; 23(16):Suppl:254-6. PubMed ID: 5727625
    [No Abstract]   [Full Text] [Related]  

  • 18. [Side effects of prednisone therapy in hematologic diseases].
    Donner L; Rejholec V; Neuwirtová R; Klener P
    Vnitr Lek; 1969 Mar; 15(3):259-68. PubMed ID: 5780047
    [No Abstract]   [Full Text] [Related]  

  • 19. [Corticosteroid therapy in diseases of the blood].
    Kassirskiĭ IA
    Sov Med; 1966 Sep; 29(9):3-12. PubMed ID: 5993702
    [No Abstract]   [Full Text] [Related]  

  • 20. [The bronchospasmolytic effect of eprazinone].
    Haber P; Burghuber O; Wolf C
    Prax Klin Pneumol; 1985 Feb; 39(2):54-8. PubMed ID: 3983078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.